Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06532877 · ClinicalTrials.gov registry record · NA

Telephone Support in Advanced Gastrointestinal Cancer

A NA study of Caregiver Burden and Gastrointestinal Neoplasm Malignant, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
488
Enrollment target
4
Study locations

NCT06532877: Recruiting NA study of Caregiver Burden and Gastrointestinal Neoplasm Malignant, sponsored by Indiana University.

NCT06532877 is a NA study of Caregiver Burden and Gastrointestinal Neoplasm Malignant that is actively recruiting participants, run by Indiana University. The registered enrollment target is 488 participants, above the 233-participant average among 41 other Caregiver Burden trials with a reported enrollment target (109% higher). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06532877, a NA study of Caregiver Burden and Gastrointestinal Neoplasm Malignant, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
488 participants
Enrollment target
4
Study locations

Study Summary

The goal of this clinical trial is to see if telephone support programs help patients and their family caregivers adjust to advanced gastrointestinal cancer. A new telephone counseling program that involves practicing strategies for managing stress and symptoms will be compared to a telephone program involving education on quality-of-life issues and psychosocial support. The main questions it aims to answer are: Does our telephone counseling program lower the negative impact of patients' fatigue on their activities, emotions, and thinking abilities compared to a telephone program involving education and support? Does our telephone counseling program lower family caregivers' feelings of burden compared to a telephone program involving education and support? Participants in both study conditions will: Complete 6 weekly telephone sessions of counseling or education/support Complete a telephone booster session Complete 3 telephone interviews over about 5 months

Primary Outcome

Seven items are rated on 11-point scales (0=no interference to 10=extreme interference) that assess the extent to which fatigue in the past week interfered with general level of activity, ability to bathe and dress, normal work activity (including housework), ability to concentrate, relations with others, enjoyment of life, and mood. The seven items are summed with higher total scores indicating greater fatigue interference. The total score range is 0 to 70. This is the primary outcome for patie

Interventions

  • BEHAVIORAL Acceptance and Commitment Therapy
  • BEHAVIORAL Education/Support

Study Locations (4)

Indiana

  • Eskenazi Health - Indianapolis
  • Indiana University Health - Indianapolis

Illinois

  • Northwestern Medicine - Chicago

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 488 participants
Start Date 2024-08-21
Est. Completion 2029-02
Phase NA
Indiana University

890 total trials

What NCT06532877 shows while recruiting

NCT06532877 is an interventional study that assigns participants to a tested intervention. The registered 488 participants enrollment target is mid-sized for trials with a published cap, above the 233-participant average among 41 other Caregiver Burden trials with a reported enrollment target (109% higher).

The record links to 2 conditions, with Caregiver Burden appearing as the primary indexed condition, and to 2 interventions - of which Acceptance and Commitment Therapy is the first listed.

NCT06532877 reports a single indexed study location in Indiana, Illinois, Texas.

Frequently Asked Questions

What is clinical trial NCT06532877 about?

NCT06532877 is a clinical study titled "Telephone Support in Advanced Gastrointestinal Cancer". The goal of this clinical trial is to see if telephone support programs help patients and their family caregivers adjust to advanced gastrointestinal cancer. A new telephone counseling program that involves practicing strategies for managing stress and symptoms will be compared to a telephone progra...

What is the current status of trial NCT06532877?

This trial is currently recruiting. It is a NA study. The enrollment target is 488 participants. The study started on 2024-08-21. Estimated completion is 2029-02.

What conditions does trial NCT06532877 study?

This clinical trial studies the following conditions: Caregiver Burden, Gastrointestinal Neoplasm Malignant.

What interventions are being tested in trial NCT06532877?

The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL), Education/Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT06532877?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06532877 being conducted?

This trial has 4 study locations across Illinois, Indiana, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Caregiver Burden

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06532877's enrollment target sits among peer trials

488 5th of 41 higher than 37 of 41 other Caregiver Burden trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Caregiver Burden trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05154669 · 488 participants · Phase 3

    Integrating Financial Coaching and Smoking Cessation Coaching

  • NCT06602479 · 488 participants · Phase 2

    A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

  • NCT06794983 · 488 participants · NA

    Calls and Coordination for Transitions of Care at Re-entry

  • NCT06948435 · 487 participants · Phase 3

    A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06532877, the US trial registry maintained by the National Library of Medicine. NCT06532877 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.